Dong Chen, MD, PhD, discusses how AI has changed the landscape for genomic testing and patient management. AI has truly revolutionized healthcare, profoundly enhancing both patient management and the ...

Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide ...

Discover what really happens in clinical trials. From potential benefits to hidden risks, learn what participants experience ...

Pharmacogenomics studies how individuals respond to drugs based on their genetic code. Using that knowledge to guide ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endome | Genmab has shared the first data on ...

The presentation titled " Utilization of Proteomic Testing in Pulmonary Nodule Risk Stratification at a Safety-Net Hospital: ...

The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share data from seven new research studies at the 2025 ASCO Annual Meeting, ...